共享决策及其与慢性乙型肝炎患者抗病毒治疗坚持的关联:单中心横截面分析
Zhuping Qian1,2, Pingmei Jiang1, Qingren Cao3
1Nursing Department, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
MDM policy & practice
|November 27, 2025
概括
慢性乙型肝炎患者的共同决策 (SDM) 超出平均水平,受性别和肝硬化影响. 促进SDM可以改善药物服药和自我有效性.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 患者坚持的研究研究.
- 健康心理学 心理健康心理学
背景情况:
- 慢性乙型肝炎 (CHB) 管理需要患者的参与.
- 共享决策 (SDM) 对于有效的治疗坚持至关重要.
- 了解影响CHB中SDM的因素至关重要.
研究的目的:
- 为了评估CHB患者的SDM水平.
- 确定影响CHB中SDM的因素.
- 评估SDM对抗病毒治疗坚持的影响.
主要方法:
- 与239名CHB患者进行的横截面研究.
- 使用了人口统计,SDM,自我效能和坚持的问卷.
- 结构方程建模分析了SDM对坚持的影响.
主要成果:
- 冠状动脉瘤患者的SDM高于平均水平 (71.99 ± 9.22).
- 在男性和肝硬化患者中观察到更高的SDM.
- SDM对自我效能 (β=0.568) 和坚持 (β=0.413) 有积极的影响.
- 自我有效性调解了SDM-坚持关系 (β=0.219).
结论:
- 医疗保健中心患者表现出良好的SDM水平,但个体差异存在.
- 促进SDM可以提高药物自我有效性和治疗坚持.
- 有针对性的干预措施可以改善SDM和随后的健康结果.
相关概念视频
Retrovirus Life Cycles
49.2K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.2K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
241
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
241
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
169
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
169
Chronic Pancreatitis II: Collaborative Care
291
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
291
Therapeutic Drug Monitoring: Affecting Factors
182
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
182


